Axsome Therapeutics to Present Five Abstracts Including New

NEW YORK, April 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...

Related Keywords

Japan ,United States ,United Kingdom ,New York ,Boston ,Massachusetts ,China ,Germany ,American ,British ,Hans Van Dongen ,Eileen Leary ,Samantha Floam ,Mark Jacobson ,Zachariah Thomas ,Stuartj Tepper ,Axsome Mo ,Darren Opland ,Drug Administration ,Sk Biopharmaceuticals Co Ltd ,Us Drug Enforcement Agency On ,Nasdaq ,Clinical Development At Axsome ,Airway Pressure ,Study Topline Data Press ,Geisel School Of Medicine At Dartmouth ,Continuous Positive Airway Pressure ,American Academy Of Neurology ,Affairs At Axsome ,Professor At Washington State University ,Corporate Communications ,Axsome Therapeutics Inc ,Annual Meeting ,Participants During ,British Columbia Cognitive Complaints Inventory ,Epworth Sleepiness Scale ,Washington State University ,Cognitive Function ,Cognitive Impairment Associated ,Excessive Daytime Sleepiness ,Obstructive Sleep Apnea ,Senior Director ,Clinical Development ,Preclinical Pharmacology ,Potential Mechanisms ,Executive Director ,Medical Affairs ,Solriamfetol Real World Experience Study ,Experience During Follow Up ,Identifying Areas ,Unmet Need Among People ,Inadequate Response ,Prior Acute Therapies ,Risk Factors ,Acute Migraine ,Geisel School ,Cognitive Health ,Apnea Participants During ,Randomized Placebo Controlled Study ,Digit Symbol Substitution Test ,Repeatable Battery ,Neuropsychological Status ,Digit Symbol Substitution ,Patient Global Impression ,Real World Experience ,Enforcement Agency ,Full Prescribing Information ,Medication Guide ,Prescribing Information ,Molecular Solubility Enhanced Inclusion Complex ,Axsome Therapeutics ,Topline Data Press Release ,Nasdaq Axsm ,Nc ,Han ,Narcolepsy ,